Catalent Inc.

108.47-1.11-1.01%Vol 656.82K1Y Perf 54.15%
Jun 15th, 2021 16:03 DELAYED
BID106.48 ASK110.62
Open109.58 Previous Close109.58
Pre-Market- After-Market108.47
 - -  - -%
Target Price
136.50 
Analyst Rating
Strong Buy 1.50
Potential %
25.84 
Finscreener Ranking
★★★★+     57.79
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     57.02
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     69.08
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap18.48B 
Earnings Rating
Buy
Price Range Ratio 52W %
66.97 
Earnings Date
4th May 2021

Today's Price Range

108.36109.82

52W Range

69.52127.68

5 Year PE Ratio Range

11.1090.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
1.09%
1 Month
5.62%
3 Months
4.78%
6 Months
8.33%
1 Year
54.15%
3 Years
161.56%
5 Years
389.26%
10 Years
-

TickerPriceChg.Chg.%
CTLT108.47-1.1100-1.01
AAPL129.64-0.8400-0.64
GOOG2 520.66-6.3800-0.25
MSFT258.36-1.5300-0.59
XOM64.332.26003.64
WFC45.460.31000.69
JNJ164.49-0.8800-0.53
FB336.75-0.0200-0.01
GE13.540.07000.52
JPM155.18-2.3900-1.52
Financial StrengthValueIndustryS&P 500US Markets
1.90
2.40
0.44
0.87
7.80
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
33.20
20.50
28.00
9.20
15.02
RevenueValueIndustryS&P 500US Markets
3.76B
22.06
13.65
13.69
Earnings HistoryEstimateReportedSurprise %
Q03 20210.730.786.85
Q02 20210.500.5816.00
Q01 20210.330.330.00
Q04 20200.810.854.94
Q03 20200.450.462.22
Q02 20200.390.390.00
Q01 20200.190.17-10.53
Q04 20190.620.654.84
Earnings Per EndEstimateRevision %Trend
6/2021 QR0.994.21Positive
6/2021 FY2.703.45Positive
9/2021 QR0.6412.28Positive
6/2022 FY3.285.13Positive
Next Report Date-
Estimated EPS Next Report0.73
Estimates Count5
EPS Growth Next 5 Years %20.90
Volume Overview
Volume656.82K
Shares Outstanding170.34M
Trades Count7.48K
Dollar Volume229.50M
Avg. Volume1.04M
Avg. Weekly Volume611.66K
Avg. Monthly Volume931.68K
Avg. Quarterly Volume1.07M

Catalent Inc. (NYSE: CTLT) stock closed at 108.47 per share at the end of the most recent trading day (a -1.01% change compared to the prior day closing price) with a volume of 657.31K shares and market capitalization of 18.48B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 13900 people. Catalent Inc. CEO is John R. Chiminski.

The one-year performance of Catalent Inc. stock is 54.15%, while year-to-date (YTD) performance is 4.23%. CTLT stock has a five-year performance of 389.26%. Its 52-week range is between 69.52 and 127.68, which gives CTLT stock a 52-week price range ratio of 66.97%

Catalent Inc. currently has a PE ratio of 36.40, a price-to-book (PB) ratio of 5.00, a price-to-sale (PS) ratio of 4.97, a price to cashflow ratio of 38.70, a PEG ratio of 2.32, a ROA of 6.07%, a ROC of 9.34% and a ROE of 16.37%. The company’s profit margin is 15.02%, its EBITDA margin is 28.00%, and its revenue ttm is $3.76 Billion , which makes it $22.06 revenue per share.

Of the last four earnings reports from Catalent Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.73 for the next earnings report. Catalent Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Catalent Inc. is Strong Buy (1.5), with a target price of $136.5, which is +25.84% compared to the current price. The earnings rating for Catalent Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Catalent Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Catalent Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 12.59, ATR14 : 2.43, CCI20 : 133.45, Chaikin Money Flow : 0.01, MACD : 0.58, Money Flow Index : 69.41, ROC : 3.21, RSI : 57.50, STOCH (14,3) : 87.49, STOCH RSI : 0.72, UO : 65.49, Williams %R : -12.51), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Catalent Inc. in the last 12-months were: Alessandro Maselli (Sold 148 shares of value $15 454 ), Aristippos Gennadios (Sold 0 shares of value $-1 691 609 ), Aristippos Gennadios (Sold 30 422 shares of value $2 631 980 ), Gregory T. Lucier (Sold 48 000 shares of value $4 324 320 ), John R. Chiminski (Sold 0 shares of value $-13 350 252 ), John R. Chiminski (Sold 407 475 shares of value $39 516 448 ), Jonathan Arnold (Sold 0 shares of value $-1 213 364 ), Jonathan Arnold (Sold 15 944 shares of value $1 459 083 ), Karen A. Flynn (Sold 2 577 shares of value $288 617 ), Kay A Schmidt (Sold 4 458 shares of value $433 745 ), Michael J. Grippo (Sold 4 056 shares of value $374 118 ), Peter Zippelius (Sold 5 392 280 shares of value $535 237 728 ), Ricardo Pravda (Sold 78 shares of value $8 145 ), Ricci S Whitlow (Sold 775 shares of value $90 911 ), Scott Gunther (Sold 0 shares of value $-264 639 ), Scott Gunther (Sold 7 364 shares of value $594 848 ), Steven L. Fasman (Sold 0 shares of value $-1 232 871 ), Steven L. Fasman (Sold 29 671 shares of value $3 030 851 ), Wetteny Joseph (Sold 0 shares of value $-262 799 ), Wetteny Joseph (Sold 9 776 shares of value $1 164 258 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (63.64 %)
7 (63.64 %)
7 (70.00 %)
Moderate Buy
2 (18.18 %)
2 (18.18 %)
1 (10.00 %)
Hold
2 (18.18 %)
2 (18.18 %)
2 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.45

Catalent Inc.

Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

CEO: John R. Chiminski

Telephone: +1 732 537-6200

Address: 14 Schoolhouse Road, Somerset 08873, NJ, US

Number of employees: 13 900

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

82%18%

Bearish Bullish

64%36%

Bearish Bullish

47%53%

News

Stocktwits